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Abstract
Background: Methylation of CpG islands of genome DNA and lysine residues of histone H3 and H4 tails regulates gene
transcription. Inhibition of polyamine synthesis by ornithine decarboxylase antizyme-1 (OAZ) in human oral cancer cell line
resulted in accumulation of decarboxylated S-adenosylmethionine (dcSAM), which acts as a competitive inhibitor of
methylation reactions. We anticipated that accumulation of dcSAM impaired methylation reactions and resulted in
hypomethylation of genome DNA and histone tails.
Methodology/Principal Findings: Global methylation state of genome DNA and lysine residues of histone H3 and H4 tails
were assayed by Methylation by Isoschizomers (MIAMI) method and western blotting, respectively, in the presence or
absence of OAZ expression. Ectopic expression of OAZ mediated hypomethylation of CpG islands of genome DNA and
histone H3 lysine 9 dimethylation (H3K9me2). Protein level of DNA methyltransferase 3B (DNMT3B) and histone H3K9me
specific methyltransferase G9a were down-regulated in OAZ transfectant.
Conclusions/Significance: OAZ induced hypomethylation of CpG islands of global genome DNA and H3K9me2 by down-
regulating DNMT3B and G9a protein level. Hypomethylation of CpG islands of genome DNA and histone H3K9me2 is a
potent mechanism of induction of the genes related to tumor suppression and DNA double strand break repair.
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Introduction
Ornithine decarboxylase (ODC; EC4.1.1.17) is the first and
rate-limiting key enzyme for polyamine biosynthesis by catalyzing
from L-ornithine to putrescine [1] and is implicated in cell
proliferation and differentiation [2]. Ornithine decarboxylase
antizyme subfamily consists of three related antizyme members
and ornithine decarboxylase antizyme-1 (OAZ) was first discov-
ered and identified as an ornithine decarboxylase (ODC)
inhibitory molecule by stimulating degradation of ODC protein
[3,4]. OAZ is known to bind various proteins and mediate
degradation or stabilization of the target proteins. These proteins
include ODC [5], antizyme inhibitor [6], cyclin D1 [7,8] and
HPV16 E2 [9]. As shown in Fig. 1, inhibition of ODC activity and
the subsequent polyamine synthesis by OAZ [10] or chemical
compound, a-difluoromethylornithine (DFMO) [5] resulted in
accumulation of dcSAM. dcSAM serves as an aminopropyl donor
for polyamine synthesis but it acts as a competitive inhibitor of S-
adenosylmethionine, virtually in all methylation reactions includ-
ing DNA, RNA, lipid and protein [5,11]. Ectopic expression of
OAZ in hamster oral cancer cells induced global hypomethylation,
and transactivated the genes related to tumor suppression and
epithelial differentiation [10]. Subsequently, we profiled the genes
induced or up-regulated in human oral cancer cells by OAZ, and
found induction of genes related to DNA double strand break
repair by non-homologous end-joining mechanism [10].
DNA methylation of CpG islands and histone modification,
particularly acetylation and methylation of lysine residues of
histone tails are tightly correlated to regulate gene expression.
Histone acetylation is generally correlated with transcriptional
activation but histone methylation regulates transcriptional
activation or repression depending on the site of lysine methylation
[12]. Histone lysine methylation occurs on six lysine residues of the
tails from histones H3 (K4, K9, K27, K36, K79) and H4 (K20)
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12554[13,14]. Each of these lysines can be mono-, di- or trimethylated
[13]. Methylation of H3K4, H3K36 and H3K79 are mainly
correlated with transcriptional activation whereas methylation of
H3K9, H3K27 and H4K20 occurs mainly in association with
transcriptional silencing [15,16]. The interdependent relationship
between DNA methylation and histone methylation is one of the
interest topics in gene regulation. H3K9 methylation and DNA
methylation are tightly associated in heterochromatin and
transcriptionally repressed euchromatic regions. Growing evidenc-
es unveiled that DNA cytosine methylation co-exists with
repressive H3K9 methylation because DNA methyltransferases,
methyl-CpG binding protein (MECP2), and heterochromatin
protein1 (HP1) recruit H3K9 specific methyltransferase to
methylate histone lysine residues [17–19]. This mechanism is
reversed in some systems [20]. H3K9 methylation is a prerequisite
for DNA methylation [21–24]. We hypothesize that accumulation
of dcSAM by ectopic OAZ expression leads to hypomethylation of
genome DNA and histone tails and the hypomethylation of
genome DNA and histone tails up-regulates or transactivates the
genes involved in DNA double strand break repair. The genomic
data serve as a foundation to understand the interrelationship
between transcription factor and chromatin based pathways. In
the present study, we screened and verified OAZ mediated global
hypomethylation of genome DNA and histone H3 and H4 tails.
Results
ODC activity
OAZ protein promotes degradation of ornithine decarboxylase
(ODC) protein and reduction of ODC enzyme activity. To
examine whether OAZ protein transcribed and translated from
the OAZ transfectant (UM1-pMT/CB6
+HuFSAZ-wt) is a biolog-
ically active protein, ODC enzyme activity assay was performed as
previously described [10]. The ODC activity in the OAZ
transfectant with ZnSO4 treatment exhibited reduced ODC
enzyme activity (1629.0661.7/picomoles CO2 per hour per
milligram protein) by 72.6% comparing with that of the mock
vector transfectant (UM-1pMT/CB6
+) treated with ZnSO4
(5930.06110.7/picomoles CO2 per hour per milligram protein)
(p,0.05). The ODC activity in the OAZ transfectant without
ZnSO4 treatment decreased (4944.16414.6/picomoles CO2 per
hour per milligram protein) by 30.3% comparing with that of the
mock vector transfectant without ZnSO4 treatment
(7084.76284.1/picomoles CO2 per hour per milligram protein)
(Fig. 2). This is probably due to the leakage of gene expression
induced by trace amount of Zn
2+ supplemented in the culture
medium. The reduction of ODC activity in the OAZ transfectant
confirmed that OAZ protein induced by ZnSO4 treatment was
biologically functional protein.
Intracellular level of polyamines and metabolites
We anticipated that reduction of ODC enzymatic activity led to
the depletion of polyamine pool and the subsequent alteration of
intracellular level of polyamine metabolites. We quantified
intracellular ODC, polyamines and metabolites level by HPLC
analysis as previously described [5]. Ectopic expression of OAZ
down-regulated ODC protein level from 51ng/10
6 cells to 8.4 ng/
10
6 cells. As anticipated, the polyamine levels dramatically
decreased as result of suppression of ODC activity. Putrescine
level decreased from 9 ng/10
6 cells to 1.3 ng/10
6 cells. Spermi-
dine level decreased from 15.1 ng/10
6 cells to 0.2 ng/10
6 cells.
Spermine level decreased from 72.8 ng/10
6 cells to 1.0 ng/10
6
cells (Fig. 3A). S-adenosylmethionine (SAM), which is a methyl
donor for all methylation reactions, was quite constant through the
experiments. The intracellular amount of SAM was 17.8 ng/10
6
cells in the OAZ transfectant and 14.3 ng/10
6 cells in the mock
vector transfectant. The intracellular level of dcSAM in the control
mock vector transfectant was 1.22 ng/10
6 cells but it drastically
increased to 87.9 ng/10
6 cells in the OAZ transfectant. The
Figure 1. Metabolic pathway coupling between polyamine
synthesis and methylation reactions. ODC is a key enzyme of
polyamine synthesis by catalyzing from L-ornithine to putrescine. OAZ
is an inhibitory molecule of ODC activity by mediating degradation of
ODC protein. SAM serves as a methyl donor in methylation reactions as
well as precursor of dcSAM production. dcSAM is an aminopropyl donor
of polyamine biosynthesis but it also acts as a competitive inhibitor of
SAM virtually in all methylation reactions. Inhibition of ODC activity
leads to polyamine depletion and dcSAM accumulation, which inhibits
methylation reactions.
doi:10.1371/journal.pone.0012554.g001
Figure 2. ODC enzymatic activity assay in mock vector and
OAZ transfectants. ODC activity (picomoles CO2 per hour per
milligram protein) of the parental UM1, the mock vector transfectant
and OAZ transfectant with and without ZnSO4 treatment was
measured. Triplicate quantification was performed. Corrected ODC
activity values were obtained by subtracting the value for blank. ODC
activity of OAZ transfectant without ZnSO4 treatment was suppressed
because trace amount of ZnSO4 in culture medium caused leakage of
OAZ gene expression.
doi:10.1371/journal.pone.0012554.g002
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from 0.66 ng/10
6 cells to 3.76 ng/10
6 cells (Fig. 3B).
Methylation state of genome DNA
As we have already published, ectopic expression of OAZ in the
hamster malignant oral keratinocytes induced global hypomethyla-
tion of CCGG sites of the genome DNA [10]. In the present study,
we examined whether the same hypomethylation was induced by
the human OAZ in human oral cancer cell line. The level of
methylated cytosines in CCGG sites was quantified by measuring




5CMP by liquid scintillation counting. The result of the
quantification is shown in Fig. 4 as a percentage of dm
5CMP. The
OAZ transfectant with and without ZnSO4 treatment exhibited
that 26.0% and 40.6% of CCGG sequences were methylated,
respectively. The parental UM1 cells with and without ZnSO4
treatment, and the mock vector transfectant with and without
ZnSO4 treatment exhibited 48.7% and 50.2%, and 40.4% and
40.9% of the internal cytosine was methylated, respectively. This
result indicates ectopic expression of OAZ is associated with
genome-wide DNA demethylation in human oral cancer cell line.
Genomic DNA of the OAZ transfectant is about 60% less
methylated than that of the mock vector transfectant.
Methylation state of histone H3 and H4 tails
Methylation state of the lysine residues of histone H3 and H4
tails links to formation of transactive euchromatin or transrepres-
sive heterochromatin depending on methylation site. Depletion of
polyamine pool by OAZ led to accumulation of dcSAM, which
acts as competitive inhibitor of SAM in methylation reactions. We
anticipated accumulation of dcSAM mediated global hypomethy-
lation of lysine residues of histone H3 and H4 tails. As the first
screening approach to explore a potential connection between
accumulation of dcSAM and alteration of global histone
methylation state, we analyzed the global changes in the
methylation status of histne H3 and H4 by western blotting.
Sixteen antibodies against mono-, di- and tri-methylation of
specific lysine residues of histone H3 and H4 were used. We could
observe a significant decrease in global level of histone H3 Lys-9
dimethylation (H3K9me2), H3K27me1, H3K27me2, an
H3K27me3 by 41.6, 14.3, 16.4 and 17.5% respectively in the
OAZ transfectant (Fig. 5A and B). The signal intensity of histone
H3 was constant among all samples loaded. In contrast, other
twelve antibodies for histones H3 (H3K4me1, H3K4me2,
H3K4me3, H3K9me1, H3K9me3, H3K36me1, H3K36me2,
H3K36me3, H3K79me2) and H4 (H4K20me1, H4K20me2,
H4K20me3) did not exhibit any significant difference between the
OAZ transfectant and the mock vector transfectant (Fig. 5A and
B). Di-methylation of histone H3K9 is a mark of constitutive
heterochromatin and gene repression. Hypomethylation of
H3K9me2 represents a change of chromatin state from hetero-
chromatin to euchromatin, which also means transcriptional
Figure 3. Intracellular level of polyamines, L-ornithine, SAM, dcSAM, SAH. Polyamine pool was depleted (A) but dcSAM and SAH, which
were potential inhibitors of methylation reactions, increased (B) in the OAZ transfectant treated with ZnSO4. Cellular level of SAM was constant
through the experiments (B).
doi:10.1371/journal.pone.0012554.g003
Figure 4. Quantification of global DNA methylation in the
parental UM1 cells, mock vector and OAZ transfectants. Global
methylation level of 59-methyl-CMP (dm59dCMP) and 59dCMP in
genome DNA of the parental UM1 cells, mock vector and OAZ
transfectant was measured by scintillation counting.
32P-labeled
dm
5CMP and CMP were produced by cleavage of the respective
genome DNAs with the restriction enzymes MspI and its methylation
sensitive isoschizomer HpaII and they were separated on a thin layer
chromatography.
doi:10.1371/journal.pone.0012554.g004
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demethylation of H3K9me2 by OAZ speculates activation of the
genes related to differentiation [10] and DNA double strand break
repair [25].
Expression level of DNMTs and G9a
We first examined whether OAZ altered the mRNA expression
level of DNMTs and G9a by qRT-PCR. Conventional RT-PCR
was performed prior to qRT-PCR to confirm that the primer set
was able to amplify single amplicon. We confirmed these PCR
primers could amplify crispy single band after 35 cycle PCR
reaction (data not shown). The subsequent qRT-PCR results
revealed that OAZ expression or ZnSO4 treatment did not affect
the expression level of DNMT1, 3A, 3B and G9a mRNA (p,0.01)
(Fig. 6). OAZ mediated global hypomethylation of genome DNA
and histone H3K9me2. DNMTs 1, 3A, 3B and G9a/GLP histone
methyltrasferase complex are involved in methylation of genome
DNA and histone H3K9me2, respectively. We hypothesized that
hypomethylation of histone tails was one of pleiotropic targets of
dcSAM-mediated hypomethylation, and all of the methylated
lysines of histone tails were hypomethylated but in fact only
H3K9me2 was hypomethylated. This unexpected result prompted
us to examine the protein level of DNMTs and G9a. Methylation
of the mammalian H3K9 is catalyzed by G9a/GLP histone
methyltransferase complex. Western blot analyses revealed the
protein level of DNMT3B (Fig. 7) and G9a (Fig. 8) was
significantly down-regulated but the protein level of DNMT1
and 3A was not altered in the OAZ transfectant. This outcome
indicates that global hypomethylation of genome DNA and
histone tails is caused by not only by a pleiotropic effect of
Figure 5. Western immunoblot analysis of global methylated lysine residues of the histone H3 and H4 in mock vector and OAZ
transfectants. Significant hypomethylation of H3K9me2 was shown in the OAZ transfectant treated with ZnSO4. Methylation status of other lysine
residues of histone H3 and H4 tails was not altered. Histone H3 and H4 proteins (17 kDa and 10 kDa, respectively) was also blotted on the same
membrane after stripping to monitor equal amount of protein loading in each lane. We show only H3K9, H3K27 and H4K20 results because
methylation of these histone tails works as transcriptional repressor (A). The value denote the relative intensity of methylated histone protein bands
of the OAZ tranfectants to that of the mock vector transfectants after being normalized to the PAN H3 and H4 bands. Intensity of the control (mock
vector transfectant without ZnSO4 treatment) was considered as 100 and other signals were expressed as relative value (B).
doi:10.1371/journal.pone.0012554.g005
Figure 6. Expression level analysis of DNMT1, 3A, 3B and G9a
mRNA in mock vector and OAZ transfectants by qRT-PCR.
Expression level of these mRNA was not altered by OAZ. The PCR result
was normalized using the -beta-actin signal. Signal of the control (mock
vector transfectant without ZnSO4 treatment) was considered as 100
and other signals were expressed as relative value.
doi:10.1371/journal.pone.0012554.g006
Figure 7. Western immunoblot analysis of DNMTs proteins in
mock vector and OAZ transfectants. Nuclear extracts were
immunoblotted with anti-DNMTs antibodies. Protein level of DNMT1
(183 kDa) and DNMT3A (101 kDa) was constant but protein level of
DNMT3B (110 kDa) was significantly decreased in the OAZ transfectant
treated with ZnSO4. The fain bands appeared in the DNMT3A and
DNMT3B blots are isoforms of DNMT3A and 3B. Oct-1 (89 kDa) was
used to monitor equal amount of protein loading in each lane.
doi:10.1371/journal.pone.0012554.g007
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DNA and histone tails.
DNMT enzyme activity
We used poly(dI-dC)poly(dI-dC) as a substrate for the DNMT
enzyme activity assay. DNMT enzyme activity was determined by
measuring incorporation of label into poly(dI-dC)poly(dI-dC)
substrate. Methyl poly(dI-dC)poly(dI-dC) production was sup-
pressed by ,65% in the OAZ transfectant with ZnSO4 treatment
comparing with those of the control transfectant and the OAZ
transfectant without ZnSO4 treatment (P,0.01) (Fig. 9). This
result revealed that decreased DNMT3B protein suppressed the
part of total DNMT activity and this decreased DNMT activity is
correlated with down-regulation of DNMT3B protein by OAZ.
Discussion
We have reported that ectopicexpressionofOAZinhamster oral
cancer cells resulted in global hypomethylation of genome DNA
[10] and induced or up-regulated expression of the genes related to
DNA double strand break repair in human oral cancer cells [25].
Aberrant methylation of CpG islands within the promoter region
inactivates gene transcription [26–28]. Covalent modifications of
histone tails also play important roles in transcription, DNA
replication, DNA break repair and chromatin condensation in
mitosis [29]. Among these histone modifications, methylation and
acetylation of histone tails are involved in regulation of gene
transcription [30,31]. In the present study, we examined the global
methylation state of genome DNA and lysine residues from histone
tails in human oral cancer cells in the absence or presence of OAZ
expression. Inhibition of polyamine synthesis by OAZ accumulated
abnormally high level of dcSAM, which acts as a competitive
inhibitor of S-adenosylmethionine virtually in all methylation
reactions. We predicted accumulation of dcSAM induced hypo-
methylation of cystine residues of CpG islands and altered
methylation marks of lysine residues of histone tails. Cytosine
residues of CCGG sites in genome DNA were globally hypomethy-
lated as anticipated but only H3K9me2 was hypomethylated
among the methylable lysine residues of histone tails. These results
prompted us to examine the protein level of DNA methyltransfer-
ases (DNMTs) and H3K9me2-specific methyltransferase G9a. Our
western blot results exhibited protein level of DNMT3B and G9a
was down-regulated in the OAZ transfectants. DNA methylation
patterns are established and maintained by the coordination of
DNA methyltransferases, DNMT1, DNMT3A and DNMT3B.
DNMT1 pursues maintenance of methylation pattern following
DNA replication, whereas DNMT3A and DNMT3B are mainly
responsible for de novo methylation [32] and maintenance of
methylation in certain regions of the genome DNA during
embryogenesis and development [33]. DNMT3B depletion in
human cancer cell lines reactivated methylation-silenced gene
expression but did not induce global or juxtacentromeric satellite
demethylation [34]. Depletion of DNMT3B by OAZ might
promote the sequence-specific DNA demethylation and induced
or up-regulated the expression of genes related to DNA break repair
but accumulation of dcSAM also contributed to random, global
DNA demethylation.
G9a histone methyltransferase, which uniquely methylates
histone H3K9, is also a major player of gene silencing [35] and
essential for early embryogenesis to regulate developmental gene
expression [36]. Methylation of H3K9me2 mediated by G9a alters
chromatin structure from relaxed euchromatin to compact
heterochromatin and represses a number of gene expression
[36–38]. Methylation of H3K9 has been known to associate with
hypermethylation of promoter CpG islands in cancer cells [39,40].
DNA methylation and H3K9 methylation tightly cooperate to
regulate gene expression. H3K9 methylation is a prerequisite for
DNA methylation [21–23] and H3K9 methylation is required for
DNA methylation [22,23]. G9a mediated DNA methylation does
not require its catalytic activity [41], suggesting that it may have
additional functions in directing DNA methylation, such as the
recruitment of DNMTs [42]. G9a protein binds to DNMT1 and
leads to enhanced DNA and histone methylation [43]. G9a
protein also recruits and binds to DNMT3A and DNMT3B
proteins through its ankyrin (ANK) domain [44], and locates them
to the sites of DNA replication. H3K9me2 plays equally important
roles in gene silencing in euchromatin and subsequent de novo
DNA methylation of embryonic and germ line genes during
normal development [41], and is necessary for the maintenance of
Figure 8. Western immunoblot analysis of G9a protein in mock
vector and OAZ transfectants. Nuclear extracts were immuno-
blotted with anti-G9a antibody. Expression of G9a protein (140 kDa)
was decreased in the OAZ transfectant treated with ZnSO4.
doi:10.1371/journal.pone.0012554.g008
Figure 9. DNMT enzymatic activity assay in mock vector and
OAZ transfectants. Total DNMT activity assay was performed. DNMT
activity was decreased by ,65% in the OAZ transfectant treated with
ZnSO4. This result is correlated with the western blot result of DNMT3B.
doi:10.1371/journal.pone.0012554.g009
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loci, and other genes in differentiated cells [45]. Li et al and Deng
et al reported inhibition of global genome DNA methylation with
5-Aza-29-deoxycytidine (5-Aza-CdR) decreased the protein ex-
pression of DNMT1 and DNMT3B [46,47]. Wozniak et al
reported that 5-Aza-CdR treatment hypomethylated global
H3K9me2 in human breast cancer cells by down-regulating
G9a protein level [48]. These data suggest that DNA demethyl-
ation may be a signal that directs the demethylation of H3K9
during DNA replication.
It is an odd result that accumulation of dcSAM did not alter
methylation state of lysine residues of histone tails other than
H3K9me2 because inhibition of methylation by dcSAM seems a
pleiotropic effect. Transcription factors also have pleiotropic effect
but their activity is tightly regulated by cis- and trans-acting
elements to regulate gene expression in tissue-, developmental
stage-, and disease-specific manner. We believe methylation
inhibition by dcSAM is not pleiotropic manner but it is also
regulated by additional cis- and tras-acting elements to target
specific sites of the genes and histone tails. The precise molecular
mechanism underlying the down-regulation of DNMT3B and
G9a proteins by OAZ remains elusive. We propose a potent
molecular mechanism that OAZ protein directly or indirectly bind
to DNMT3B and/or G9a proteins and promotes their degrada-
tion. OAZ protein has been known to bind various proteins and
promotes their degradation [7–9,49–51]. The current our result
underscores the complex relationship of histone methylation and
susceptibility to DNA methylation. These evidences suggest that
expression of genes related to DNA repair [25] may be activated




Human oral cancer cell line, UM1 [52] and the zinc-inducible
OAZ transfectant (pMT/CB6
+HuFSAZ-wt) and the mock vector
transfectant (UM1-pMT/CB6
+) were cultured as previously
described [25]. The expression of OAZ gene from the pMT/
CB6
+HuFSAZ-wt was induced by 100 mM ZnSO4 treatment and
the protein samples were harvested after one week ZnSO4
treatment.
ODC activity assay
To check whether OAZ protein translated from the OAZ
transfectant was biologically active protein in the U1 cells, ODC
enzymatic activity was assayed as previously described [10].
Briefly, the ODC activity was quantified the release of [
14C] CO2
during ODC-catalyzed conversion of L-ornithine to putrescine.
The reaction mixture contained 50 ml of cell lysate prepared from
the OAZ transfectant and the mock vector transfectant with and
without ZnSO4 treatment, 75 ml of 100 mM glycyl-glycine
(pH 7.2), 0.2 mM pyridoxal phosphate, 4 mM dithiothreitol,
0.4 mM L-ornithine, and 0.25 mCi [
14C] l-ornithine. Reactions
were carried out at 37uC for 2hr and terminated by heating at
85uC for 5 min. [
14C]CO2 was trapped with Whatman 3-mm
paper filter spotted wit 10 ml of 10% w/v KOH and quantified by
scintillation counter. Triplicate assays were performed. Control
sample was the blank containing lysis buffer in place of the
supernatant. Corrected ODC activity values were obtained by
subtracting values for blank and stated as picomoles CO2 per hour
per milligram protein. The statistic analysis was performed by One
factor ANOVA analysis.
HPLC analysis
Intracellular amount of ODC, polyamines, SAM, dcSAM and
SAH (S-adenosylhomecysteine) was quantified by reversed-phase
HPLC analysis. The whole cell lysates from the OAZ transfectant
and the mock vector transfectat with and without ZnSO4
treatment were prepared in 0.2 M perchloric acid. The cell
lysates were centrifuged at 13,000 X g for 10 min and the
supernatants were subjected to reversed-phase HPLC analysis on a
Supercosil LC-18-DB column (4.66250 mm, 5 mm pore size)
equilibrated with 0.2% triethylamine-phosphoric acid (pH 4.0).
Elution was achieved with 20 min linear gradient from 0–10%
acetonitrile. The aliquots were subjected to chromatographic
separation. The standards for ODC, polyamines, SAM and SAH
were purchased from Sigma-Aldrich. The standard for dcSAM
was a kind gift from Dr. Keijiro Samejima of Josai University in
Japan.
Western blot analysis of methyl-histone tails
Methylation status of each histone tails was verified by western
blotting. The protin samples for western blot analyses of histone
tails were prepared by directly adding 500 ml of Laemmli’s SDS-
sample buffer into 100mm culture plate and the cells were
harvested by scrapping with a rubber policeman. The harvested
cells were boiled for 15 minutes in the sample buffer and
centrifuged at 16,000 X g for 30 minutes. The protein amount was
estimated by the cell number of the replicated culture. The
extracted proteins equivalent to 1610
5 –5 610
5 cells were loaded
and separated in 15% SDS-PAGE gel, transferred to a PVDF
membrane, blocked with 5% milk in TBS-T buffer and blotted
with each antibody at recommended dilution by manufactures.
The signals were developed with Pierce’s SuperSignalH West Pico
Chemiluminescent Substrate and autographed on film. To
eliminate potential artifact caused by zinc, we repeated the same
experiments using the pCI-neo-hOAZ tarsnfectants (pCI-neo-
hOAZ-UM1). The antibodies used in this study were purchased
from Upstate Biotechnology. The antibodies and their catalog
numbers are; pan-histone H3 (07-690), pan-histone H4 (05-858),
H3K4me1 (07-436), H3K4me2 (07-030), H3K4me3 (07-473),
H3K9me1 (07-450), H3K9me2 (07-441), H3K9me3 (07-442),
H3K27me1 (07-448), H3K27me2 (07-452), H3K27me3 (05-851),
H3K36me1 (05-800), H3K36me2 (07-369), H3K36me3 (05-801),
H3K79me2 (05-835), H4K20me1 (05-735), H4K20me2 (07-367),
H4K20me3 (07-463). The secondary antibodies used were HRP-
labeled goat anti-mouse IgG (PerkinElmer, NEF822001EA) and
HRP-labeled goat anti-rabbit IgG (PerkinElmer, NEF812001EA).
The intensity of each band was measured and analyzed using
ImageJ software provided by NIH (http://rsb.info.nih.gov/ij/).
Quantitative real-time PCR assay of DNMTs and G9a
Expression level of DNMTs and G9a mRNAs was quantified by
quantitative real-time PCR (qRT-PCR). Total RNA was isolated
from the OAZ and the mock vector transfectants using TRIzolH
reagent (Invitrogen) according to the manufacture’s protocol. The
PCR primers were designed using MacVector version 7.2 software
based on the cDNA sequences that were downloaded from the
NCBI database. The qRT-PCR reactions were performed using a
LightCycler with LightCycler FastStart DNA Master SYBR
Green I kit. Amplification of sample cDNA was monitored with
the fluorescent DNA binding dye SYBR Green in combination
with an ABI 5700 sequence detection system. b-actin was used as
an endogenous control for normalization. The PCR primer
sequences, optimal annealing temperatures, and amplicon sizes
are listed in Table 1. The statistic analysis was performed by One
factor ANOVA analysis.
DNA and Histone Demethylation
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The nuclear extract was prepared from the OAZ and the mock
vector transfectants using NE-PERH Nuclear and Cytoplasmic
Extraction Reagents (Thermo Scientific) according to the
manufacture’s protocol. Fifty mg of nuclear extract of each sample
was loaded and separated in 5% SDS-PAGE gel and the protein
was transferred onto a PVDF membrane. The subsequent western
blotting was performed as described above. The antibodies used
for this study were a rabbit polyclonal anti-human DNMT1
antibody (abcam, ab19905, 1:500), a rabbit-polyclonal anti-mouse
DNMT3A antibody (abcam, ab23565, 1:200), a rabbit polyclonal
anti-mouse DNMT3B antibody (abcam, ab16049, 1:300) and a
rabbit polyclonal anti-human G9a antibody (Upstate Biotechnol-
ogy, 07-551,1:1,000). The equal amount of sample loading was
monitored and confirmed by Oct-1signal using a rabbit polyclonal
anti-human Oct-1 antibody (Santa Cruz Biotechnology, Inc., sc-
232, 1:1,000).
DNMT enzyme activity assay
DNMT enzyme activity was determined by the method of
Belinsky et al with minor modifications [53]. Cell lysate was
prepared in lysis buffer by freezing-thawing three times and
centrifuged to remove cell debris. Cell lysate containing 20 mg
protein (125 ml) was mixed with 125 ml reaction mixture (20 mM
Tris HCl, pH=7.4, 25% glycerol, 5 mM EDTA, 1 mM DTT,
5 mCi [methyl-3H]-S-adenosyl-L-methionine, 4 mg poly [dI-
dC]poly[dI-dC], 25 mg BSA) and incubated for 2 h at 37uC.
Reactions were stopped and the DNA was extracted with
Phenol:chrolform extraction method. The aqueous solution was
supplemented with 0.1N NaOH and incubated for 2 hr at 50uC.
The reaction mixture was neutralized with 1N HCl. DNA was
precipitated with 20% TCA and trapped on G/C filter. The
radioactivity was counted with a scintillation counter. The statistic
analysis was performed by One factor ANOVA analysis.
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